These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3835638)

  • 1. [Ketoconazole in the treatment of advanced cancer of the prostate: experience with 14 patients].
    Castillo Cádiz O; Martínez Sanz P
    Rev Med Chil; 1985 Apr; 113(4):309-11. PubMed ID: 3835638
    [No Abstract]   [Full Text] [Related]  

  • 2. Ketoconazole high dose (H.D.) in the management of hormonally pretreated patients with progressive metastatic prostate cancer.
    Debruyne FM; Witjes FA
    Prog Clin Biol Res; 1987; 243A():301-13. PubMed ID: 3659003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High dosage ketoconazole therapy in the treatment of advanced prostatic cancer].
    Flamm J; Sagaster P; Teich G; Köhn H; Miksche M
    Urologe A; 1988 Mar; 27(2):111-6. PubMed ID: 3376369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose ketoconazole with replacement doses of hydrocortisone in patients with progressive androgen independent prostate cancer.
    Harris KA; Weinberg V; Bok RA; Kakefuda M; Small EJ
    J Urol; 2002 Aug; 168(2):542-5. PubMed ID: 12131305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer metastasis to supraclavicular lymph node.
    Hobdy EM; Shafi NQ; Kummar S
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):223-4; discussion 224. PubMed ID: 16163185
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II study of mitoxantrone and ketoconazole for hormone-refractory prostate cancer.
    Eklund J; Kozloff M; Vlamakis J; Starr A; Mariott M; Gallot L; Jovanovic B; Schilder L; Robin E; Pins M; Bergan RC
    Cancer; 2006 Jun; 106(11):2459-65. PubMed ID: 16615097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketoconazole therapy for advanced prostate cancer.
    Trachtenberg J; Pont A
    Lancet; 1984 Aug; 2(8400):433-5. PubMed ID: 6147504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of ketoconazole plus granulocyte-macrophage colony-stimulating factor for prostate cancer: effect of extent of disease on outcome.
    Ryan CJ; Weinberg V; Rosenberg J; Fong L; Lin A; Kim J; Small EJ
    J Urol; 2007 Dec; 178(6):2372-6; discussion 2377. PubMed ID: 17936834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications of ketoconazole in prostatic cancer.
    Denis L; Chaban M; Mahler C
    Prog Clin Biol Res; 1985; 185A():319-26. PubMed ID: 4034578
    [No Abstract]   [Full Text] [Related]  

  • 10. Ketoconazole in advanced prostate cancer.
    Percy LA
    Ann Pharmacother; 1992 Dec; 26(12):1527-9. PubMed ID: 1482810
    [No Abstract]   [Full Text] [Related]  

  • 11. Ketoconazole retains activity in advanced prostate cancer patients with progression despite flutamide withdrawal.
    Small EJ; Baron AD; Fippin L; Apodaca D
    J Urol; 1997 Apr; 157(4):1204-7. PubMed ID: 9120902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects.
    Trump DL; Havlin KH; Messing EM; Cummings KB; Lange PH; Jordan VC
    J Clin Oncol; 1989 Aug; 7(8):1093-8. PubMed ID: 2474059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of intermediate-dose ketoconazole in hormone refractory prostate cancer.
    Wilkinson S; Chodak G
    Eur Urol; 2004 May; 45(5):581-4; discussion 585. PubMed ID: 15082199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melphalan in metastatic cancer of the prostate: a pilot study.
    Franks CR
    Cancer Treat Rep; 1979 Feb; 63(2):228-9. PubMed ID: 445500
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of high-dose ketoconazole in patients with androgen-independent prostatic cancer.
    Eichenberger T; Trachtenberg J
    Am J Clin Oncol; 1988; 11 Suppl 2():S104-7. PubMed ID: 3242385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketoconazole therapy in advanced prostatic cancer.
    Trachtenberg J
    J Urol; 1984 Jul; 132(1):61-3. PubMed ID: 6328052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a Dutch Phase II trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer.
    Debruyne FM; Karthaus HF; Schröder FH; de Voogt HJ; de Jong FH; Klijn JG
    Prog Clin Biol Res; 1985; 185A():251-70. PubMed ID: 3929265
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aminoglutethimide in the treatment of advanced prostatic cancer].
    Bauer HW; Schmeller NT; Schmiedt E
    Urologe A; 1985 Jan; 24(1):46-8. PubMed ID: 4039084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose ketoconazole to untreated stage D prostate cancer.
    Aabo K; Kjaer M; Hansen HH
    Eur J Cancer Clin Oncol; 1988 Mar; 24(3):431-7. PubMed ID: 3383945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
    Nickel CJ; Morales A
    Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.